Vigonvita Life Sciences Buys Back 42,200 H Shares; Treasury Stock Rises to 344,000 Units

Bulletin Express11-03

Hong Kong, 3 November 2026 – Vigonvita Life Sciences Co., Ltd. announced that it repurchased 42,200 H shares on the Hong Kong Stock Exchange on 3 November 2026 under its existing share-repurchase mandate approved on 30 June 2026.

• Transaction details – Repurchase volume: 42,200 H shares – Price range: HKD 75.65 – HKD 80.50 per share – Volume-weighted average price: approximately HKD 79.68 per share – Total consideration: about HKD 3.36 million

• Capital structure impact – Issued shares (excluding treasury) fell by 0.03 % to 166.55 million. – Treasury stock increased to 344,000 shares, equivalent to roughly 0.21 % of the 166.90 million total issued shares. – The company’s overall issued share count remains unchanged at 166.90 million, as repurchased shares are held in treasury.

• Repurchase mandate utilisation – Authorised shares for repurchase: 6.67 million – Cumulative shares repurchased since mandate approval: 344,000, representing 0.52 % of the share base at mandate inception.

• Post-repurchase restrictions – In accordance with Hong Kong listing rules, Vigonvita is subject to a moratorium on issuing new shares or disposing of treasury shares until 2 December 2026.

The company confirmed that all transactions complied with the Hong Kong Stock Exchange’s Main Board Rules and that no material changes have occurred to the repurchase mandate’s explanatory statement filed on 4 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112633191?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-11-03 19:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112633191","market":"us","top_or_hot":-1,"title":"Vigonvita Life Sciences Buys Back 42,200 H Shares; Treasury Stock Rises to 344,000 Units","media":"Bulletin Express","content":"<p>Hong Kong, 3 November 2026 – Vigonvita Life Sciences Co., Ltd. announced that it repurchased 42,200 H shares on the Hong Kong Stock Exchange on 3 November 2026 under its existing share-repurchase mandate approved on 30 June 2026.</p>\n<p>• Transaction details  \n  – Repurchase volume: 42,200 H shares  \n  – Price range: HKD 75.65 – HKD 80.50 per share  \n  – Volume-weighted average price: approximately HKD 79.68 per share  \n  – Total consideration: about HKD 3.36 million</p>\n<p>• Capital structure impact  \n  – Issued shares (excluding treasury) fell by 0.03 % to 166.55 million.  \n  – Treasury stock increased to 344,000 shares, equivalent to roughly 0.21 % of the 166.90 million total issued shares.  \n  – The company’s overall issued share count remains unchanged at 166.90 million, as repurchased shares are held in treasury.</p>\n<p>• Repurchase mandate utilisation  \n  – Authorised shares for repurchase: 6.67 million  \n  – Cumulative shares repurchased since mandate approval: 344,000, representing 0.52 % of the share base at mandate inception.</p>\n<p>• Post-repurchase restrictions  \n  – In accordance with Hong Kong listing rules, Vigonvita is subject to a moratorium on issuing new shares or disposing of treasury shares until 2 December 2026.</p>\n<p>The company confirmed that all transactions complied with the Hong Kong Stock Exchange’s Main Board Rules and that no material changes have occurred to the repurchase mandate’s explanatory statement filed on 4 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vigonvita Life Sciences Buys Back 42,200 H Shares; Treasury Stock Rises to 344,000 Units</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVigonvita Life Sciences Buys Back 42,200 H Shares; Treasury Stock Rises to 344,000 Units\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-11-03 19:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong, 3 November 2026 – Vigonvita Life Sciences Co., Ltd. announced that it repurchased 42,200 H shares on the Hong Kong Stock Exchange on 3 November 2026 under its existing share-repurchase mandate approved on 30 June 2026.</p>\n<p>• Transaction details  \n  – Repurchase volume: 42,200 H shares  \n  – Price range: HKD 75.65 – HKD 80.50 per share  \n  – Volume-weighted average price: approximately HKD 79.68 per share  \n  – Total consideration: about HKD 3.36 million</p>\n<p>• Capital structure impact  \n  – Issued shares (excluding treasury) fell by 0.03 % to 166.55 million.  \n  – Treasury stock increased to 344,000 shares, equivalent to roughly 0.21 % of the 166.90 million total issued shares.  \n  – The company’s overall issued share count remains unchanged at 166.90 million, as repurchased shares are held in treasury.</p>\n<p>• Repurchase mandate utilisation  \n  – Authorised shares for repurchase: 6.67 million  \n  – Cumulative shares repurchased since mandate approval: 344,000, representing 0.52 % of the share base at mandate inception.</p>\n<p>• Post-repurchase restrictions  \n  – In accordance with Hong Kong listing rules, Vigonvita is subject to a moratorium on issuing new shares or disposing of treasury shares until 2 December 2026.</p>\n<p>The company confirmed that all transactions complied with the Hong Kong Stock Exchange’s Main Board Rules and that no material changes have occurred to the repurchase mandate’s explanatory statement filed on 4 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02630","symbol_name":"旺山旺水-B","start_time":0,"source_url":"","article_id":"1112633191","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112633191","pubTimestamp":1793704885,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong, 3 November 2026 – Vigonvita Life Sciences Co., Ltd. announced that it repurchased 42,200 H shares on the Hong Kong Stock Exchange on 3 November 2026 under its existing share-repurchase...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02630":"旺山旺水-B"},"translate_title":"Vigonvita Life Sciences回购42,200股H股；美国库存升至 344,000 股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02630":1},"content_text":"Hong Kong, 3 November 2026 – Vigonvita Life Sciences Co., Ltd. announced that it repurchased 42,200 H shares on the Hong Kong Stock Exchange on 3 November 2026 under its existing share-repurchase mandate approved on 30 June 2026.\n• Transaction details  \n  – Repurchase volume: 42,200 H shares  \n  – Price range: HKD 75.65 – HKD 80.50 per share  \n  – Volume-weighted average price: approximately HKD 79.68 per share  \n  – Total consideration: about HKD 3.36 million\n• Capital structure impact  \n  – Issued shares (excluding treasury) fell by 0.03 % to 166.55 million.  \n  – Treasury stock increased to 344,000 shares, equivalent to roughly 0.21 % of the 166.90 million total issued shares.  \n  – The company’s overall issued share count remains unchanged at 166.90 million, as repurchased shares are held in treasury.\n• Repurchase mandate utilisation  \n  – Authorised shares for repurchase: 6.67 million  \n  – Cumulative shares repurchased since mandate approval: 344,000, representing 0.52 % of the share base at mandate inception.\n• Post-repurchase restrictions  \n  – In accordance with Hong Kong listing rules, Vigonvita is subject to a moratorium on issuing new shares or disposing of treasury shares until 2 December 2026.\nThe company confirmed that all transactions complied with the Hong Kong Stock Exchange’s Main Board Rules and that no material changes have occurred to the repurchase mandate’s explanatory statement filed on 4 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112633191","isCrawlerRequest":true}